substance p has been researched along with Acute Brain Injuries in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gabrielian, L; Helps, SC; Leonard, AV; Thornton, E; Turner, RJ; Vink, R | 1 |
| Caldwell, CC; Goodman, MD; Hanseman, D; Lentsch, AB; Pritts, TA; Remick, DG; Robinson, B; Stepien, D; Yang, S | 1 |
| Almeida, T; Argueso, M; Cáceres, JJ; Hernández, M; Jiménez, A; Lorente, L; Martín, MM; Ramos, L; Solé-Violán, J | 1 |
| Blumbergs, PC; Cernak, I; Donkin, JJ; Nimmo, AJ; Vink, R | 1 |
| Al-Amin, HA; Atweh, S; El-Rawas, R; Jaber, M; Saadé, NE; Thiriet, N | 1 |
| Chang, YW; Saab, C; Tan, A; Waxman, S | 1 |
| Blumbergs, PC; Manavis, J; Sarvestani, GT; Vink, R; Zacest, AC | 1 |
| van den Heuvel, C; Vink, R | 1 |
| Harford-Wright, E; Thornton, E; Vink, R | 1 |
| Blumbergs, PC; Cernak, I; Donkin, JJ; Vink, R | 1 |
| Carthew, HL; Vink, R; Ziebell, JM | 1 |
| Amenta, PS; Awe, OO; Elliott, MB; Jallo, JI; Oshinsky, ML | 1 |
| Corrigan, F; Ghabriel, M; Leonard, A; Van Den Heuvel, C; Vink, R | 1 |
| Cernak, I; Cruz, MI; Donkin, JJ; Nimmo, AJ; Vink, R | 1 |
| Donkin, JJ; Hassan, I; Turner, RJ; Vink, R | 1 |
| Turner, R; Vink, R | 1 |
| Choi, SC; Garcia, CI; Kontos, HA; Levasseur, JE; Moskowitz, MA; Patterson, JL | 1 |
| Cernak, I; Nimmo, AJ; Vink, R | 1 |
5 review(s) available for substance p and Acute Brain Injuries
| Article | Year |
|---|---|
Substance P antagonists as a novel intervention for brain edema and raised intracranial pressure.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Disease Models, Animal; Humans; Intracranial Hypertension; Receptors, Tachykinin; Substance P; Time Factors | 2013 |
Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury.
Topics: Animals; Brain Injuries; Humans; Kinins; Models, Biological; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Substance P; Treatment Outcome | 2010 |
Substance P in traumatic brain injury.
Topics: Animals; Brain Injuries; Humans; Receptors, Neurokinin-1; Substance P; Trigeminal Nerve | 2007 |
Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke.
Topics: Animals; Brain Edema; Brain Injuries; Humans; Neurogenic Inflammation; Neurokinin-1 Receptor Antagonists; Stroke; Substance P | 2007 |
An overview of new and novel pharmacotherapies for use in traumatic brain injury.
Topics: Brain Injuries; Clinical Trials as Topic; Cyclosporine; Gonadal Steroid Hormones; Humans; Magnesium; Substance P | 2001 |
13 other study(ies) available for substance p and Acute Brain Injuries
| Article | Year |
|---|---|
Substance P mediates reduced pneumonia rates after traumatic brain injury.
Topics: Adult; Age Factors; Aged; Animals; Boston; Brain Injuries; Female; Head Injuries, Closed; Humans; Injury Severity Score; Male; Mice; Mice, Inbred ICR; Middle Aged; Neurokinin-1 Receptor Antagonists; Pneumonia; Respiration, Artificial; Sex Factors; Substance P; Trauma Centers; Wounds, Nonpenetrating | 2014 |
Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury.
Topics: Adult; Aged; Biomarkers; Brain Injuries; Female; Humans; Male; Middle Aged; Mortality; Prospective Studies; Severity of Illness Index; Substance P | 2015 |
Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury.
Topics: Animals; Brain Edema; Brain Injuries; Capillary Permeability; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Magnetic Resonance Imaging; Male; Microscopy, Confocal; Microscopy, Immunoelectron; Motor Activity; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Substance P; Tryptophan | 2009 |
Developmental changes in the mRNA expression of neuropeptides and dopamine and glutamate receptors in neonates and adult rats after ventral hippocampal lesion.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Brain Injuries; Dynorphins; Enkephalins; Female; Gene Expression Regulation, Developmental; Hippocampus; Ibotenic Acid; Male; Neuropeptides; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Substance P | 2009 |
Unilateral focal burn injury is followed by long-lasting bilateral allodynia and neuronal hyperexcitability in spinal cord dorsal horn.
Topics: Action Potentials; Analysis of Variance; Animals; Brain Injuries; Calcitonin Gene-Related Peptide; CD11b Antigen; Disease Models, Animal; Functional Laterality; Hyperesthesia; Male; Microglia; p38 Mitogen-Activated Protein Kinases; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Posterior Horn Cells; Rats; Spinal Cord; Substance P | 2010 |
Substance P immunoreactivity increases following human traumatic brain injury.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amyloid beta-Protein Precursor; Brain; Brain Injuries; Case-Control Studies; Child; Child, Preschool; Female; Glial Fibrillary Acidic Protein; Humans; Male; Middle Aged; Postmortem Changes; Substance P; Ubiquitin Thiolesterase; Up-Regulation; Young Adult | 2010 |
Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain Injuries; Captopril; Cerebral Cortex; Disease Models, Animal; Enalapril; Gene Expression Regulation; Male; Motor Activity; Movement Disorders; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Substance P | 2010 |
A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury.
Topics: Animals; Brain Edema; Brain Injuries; Diffuse Axonal Injury; Disease Models, Animal; Male; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Substance P; Treatment Outcome | 2011 |
Substance P-induced changes in cell genesis following diffuse traumatic brain injury.
Topics: Animals; Brain Injuries; Cell Differentiation; Male; Microglia; Neurogenesis; Neurokinin-1 Receptor Antagonists; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Tryptophan | 2012 |
Nociceptive neuropeptide increases and periorbital allodynia in a model of traumatic brain injury.
Topics: Animals; Brain Injuries; Brain Stem; Calcitonin Gene-Related Peptide; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Headache; Hyperalgesia; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neuropeptides; Nociception; Somatosensory Cortex; Substance P | 2012 |
A substance P antagonist improves outcome in female Sprague Dawley rats following diffuse traumatic brain injury.
Topics: Animals; Brain Injuries; Disease Models, Animal; Female; Motor Activity; Rats; Rats, Sprague-Dawley; Substance P; Tryptophan | 2012 |
A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats.
Topics: Animals; Brain Injuries; Homeostasis; Magnesium; Magnesium Deficiency; Magnetic Resonance Spectroscopy; Male; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Substance P; Tryptophan | 2004 |
Effect of neonatal capsaicin treatment on neurogenic pulmonary edema from fluid-percussion brain injury in the adult rat.
Topics: Animals; Animals, Newborn; Brain Injuries; Capsaicin; Hemorrhage; Histamine Antagonists; Neurons, Afferent; Percussion; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Substance P; Surface Tension | 1993 |